Back

Orthostatic blood pressure changes and incident atrial fibrillation in patients with hypertension: Insights from the SPRINT trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Hypertension target organ damage Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jue Wang

Beijing (China)

8 More presentations in this session

Presentation thumbnail
Diagnostic and prognostic value of ECG-predicted hypertension mediated left ventricular hypertrophy using machine learning
Doctor H. Naderi (London, GB)
Abstract Slides Video
Presentation thumbnail
Carotid-Femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes
Doctor A. Maloberti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance (CMR) height-based allometric scaling in Southeast Asians; implications in the diagnosis and prognosis of left ventricular hypertrophy (LVH): the REMODEL study
Mr C. Lee (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults
Doctor R. Ananda (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of changes in left heart geometry on predicting new-onset atrial fibrillation in patients with hypertension
Assistant Professor H. KIM (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension target organ damage

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Exploring the overlap: prevalence and predictors of orthostatic hypotension in heart failure
thumbnail
Congress Presentation
Relative blood pressure increase is associated with subsequent atrial fibrillation episodes in long-term out-patient monitoring: TriggersAF
thumbnail
Congress Presentation
Differences in resting sympathetic nervous activity between orthostatic hypertension, conventional hypertension, and healthy individuals.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources